Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-11-06
2007-11-06
Russel, Jeffrey Edwin (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S328000
Reexamination Certificate
active
10519524
ABSTRACT:
The present invention provides a non-T cell binding peptide and its analogs used for the treatment of rheumatoid arthritis. The polypeptide therapeutic agent can specifically inhibit abnormal immune responses of the rheumatoid arthritis, and fundamentally control the progression of this disease with effect on the initiating factor of the disease development.
REFERENCES:
patent: 2002/0037844 (2002-03-01), Myers et al.
patent: 1183784 (1998-06-01), None
patent: 1310724 (2001-08-01), None
patent: WO96/41644 (1996-12-01), None
patent: WO98/33811 (1998-08-01), None
Andersson et al. Definition of MHC and T cell receptor contacts . . . Proceedings of the National Academy of Sciences USA. Jun. 1998, vol. 95, pp. 7574-7579.
Gordon & Rees LLP
Russel Jeffrey Edwin
LandOfFree
Non-T cell binding peptides and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-T cell binding peptides and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-T cell binding peptides and their uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3845461